• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.63%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    11.02 Down 0.39(3.42%) 4:00PM EDT
    |After Hours : 11.02 0.00 (0.00%) 5:16PM EDT
    Add to Portfolio
    Prev Close:11.41
    Open:11.40
    Bid:11.00 x 1000
    Ask:11.85 x 1500
    1y Target Est:23.36
    Beta:5.64
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:10.93 - 11.53
    52wk Range:10.85 - 18.48
    Volume:2,229,671
    Avg Vol (3m):1,603,390
    Market Cap:1.14B
    P/E (ttm):N/A
    EPS (ttm):-1.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for KERX

    Comparison

    Symbol% ChgMkt Cap
    KERXDown 3.42%1.14B
    BAXDown 1.08%38.25B
    SHPGDown 2.41%48.70B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):109.19
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.96
    Quarterly EPS Est (Mar-15) :-0.30
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.11

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback